Overview
This entry refers to a group of mitochondrial disorders caused by problems with how mitochondrial DNA (mtDNA) is read and used to make proteins. Mitochondria are tiny structures inside nearly every cell in your body that produce energy, much like power plants. For mitochondria to work properly, their own small set of DNA must be correctly copied (transcribed) and translated into proteins. When there are defects in this process, the mitochondria cannot produce enough energy, and this leads to disease. Please note that this specific Orphanet classification (ORPHA:309139) is now marked as 'OBSOLETE,' meaning it has been retired or reorganized into more specific disease categories. However, the underlying conditions it described are very real and still actively studied and treated. Symptoms of mitochondrial transcription or translation defects can vary widely but often affect organs that need the most energy, such as the brain, muscles, heart, and liver. Common problems include muscle weakness, developmental delays, seizures, hearing loss, vision problems, and poor growth. Some patients experience episodes of worsening symptoms during illness or stress, known as metabolic crises. The severity ranges from mild symptoms appearing in adulthood to severe, life-threatening disease in newborns. There is currently no cure for these conditions. Treatment focuses on managing symptoms, supporting energy production with supplements like coenzyme Q10 and certain vitamins, and preventing metabolic crises. Research into gene therapy and other advanced treatments is ongoing and offers hope for the future.
Also known as:
Key symptoms:
Muscle weaknessExtreme fatigue and low energyDevelopmental delays in childrenSeizures or epilepsyHearing lossVision problems or vision lossPoor growth and failure to thriveDifficulty with balance and coordinationHeart problems (cardiomyopathy)Liver dysfunctionLactic acidosis (buildup of acid in the blood)Difficulty swallowing or feedingIntellectual disabilityStroke-like episodesKidney problems
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA.
Start the conversation →Latest news about OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA
No recent news articles for OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific genetic defect is causing my (or my child's) condition, and what does it mean for prognosis?,Which organs should be monitored regularly, and how often should screening tests be done?,What supplements or medications are recommended, and what is the evidence behind them?,Are there any medications, anesthetics, or activities we should avoid?,What should we do during an illness or if we suspect a metabolic crisis?,Are there any clinical trials or emerging therapies we should know about?,Should other family members be tested, and what are the chances of this condition occurring in future children?
Common questions about OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA
What is OBSOLETE: Mitochondrial disorder due to a transcription or a translation defect of mitochondrial DNA?
This entry refers to a group of mitochondrial disorders caused by problems with how mitochondrial DNA (mtDNA) is read and used to make proteins. Mitochondria are tiny structures inside nearly every cell in your body that produce energy, much like power plants. For mitochondria to work properly, their own small set of DNA must be correctly copied (transcribed) and translated into proteins. When there are defects in this process, the mitochondria cannot produce enough energy, and this leads to disease. Please note that this specific Orphanet classification (ORPHA:309139) is now marked as 'OBSOLE